title: The management of patients with peripheral arterial disease and intermittent claudication. Actual recommendations.
abstract: In the general context of increasing prevalence of cardiovascular risk factors in European population, we face with a significant rise of the incidence of atherothrombotic diseases. Peripheral arterial disease (PAD) represented for a long time a peripheral interest for cardiologist. The epidemiological studies in the latest years determine a reconsideration of the medical attitude in respect of PAD, motivated by an increase in its prevalence and, on the other hand, by the significant cardiovascular risk this disease carries with. Taking into account that fact and aiming at a better medical approach of these patients, we realized a review regarding therapeutic methods in patients with PAD and intermittent claudication based on the latest medical publications and in accord with the guide in force at the moment.
authors.affiliation: Floreasca Emergency Hospital, Department of Cardiology, Bucharest, Romania. tirziuc@yahoo.com
authors.forename: Cristina
authors.initials: C
authors.lastname: Tîrziu
authors.forename: Elisabeta
authors.initials: E
authors.lastname: Bădilă
authors.forename: Florentina
authors.initials: F
authors.lastname: Mehic
authors.forename: S
authors.initials: S
authors.lastname: Ghiorghe
authors.forename: Daniela
authors.initials: D
authors.lastname: Bartoş
mesh_terms: D000465:Algorithms; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology; D057510:Endovascular Procedures / Q000379:methods; D006801:Humans; D007383:Intermittent Claudication / Q000453:epidemiology / Q000601:surgery / Q000628:therapy*; D058729:Peripheral Arterial Disease / Q000453:epidemiology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D010975:Platelet Aggregation Inhibitors